Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 19, Issue 1

January-February 2022

In this Issue

Ask the Hematopathologists
Features
Headlines from Washington
President's Column
Year’s Best

Ask the Hematopathologists

Germline Disease in Older Patients: The Case for Vigilance

Zaynab Al-Duwal, MD,Ashley Cunningham, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Features

Reliving #ASH21: The Historic 63rd ASH Annual Meeting

Naseema Gangat, MBBS

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Headlines from Washington

A Look Back at 2021 Shows a Year Full of Creative Advocacy

ASH Staff

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

President's Column

Science Versus the Rising Tide of Distrust

Jane N. Winter, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Year’s Best

Oral Maintenance Therapy to Improve Survival in Older Patients With AML

Nathan Klose, MBBS, FRACP,Steven Lane, MBBS, PhD, FRACP, FRCPA

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Solid Tumor TIL Therapy Is Infiltrating Multiple Centers With Lympho-“sights” Set on Becoming Standard of Care

Frederick L. Locke, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Battle of the Clones: Somatic Genetic Rescue of Pediatric Patients With MDS Teaches Us About MDS Biology in 2021 and a Platform for the Future

Amy DeZern, MD, MHS

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

From Myth to Reality: Achieving a Second Remission in Acute Lymphoblastic Leukemia

Kristen M. O'Dwyer, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

The 2021 Year’s Best

Laura C. Michaelis, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Emerging Evidence for Old Drugs (Mycophenolate) and New Ones (Fostamatinib) in the Treatment of Immune Thrombocytopenia

Eric Tseng, MD, MScCH, FRCPC

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Anticoagulants for Hospitalized Patients With COVID-19: The Year of Randomized Controlled Trials

Damon Houghton, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

iStopMM: A Monumental Effort

Malin Hultcrantz, MD, PhD,Saad Usmani, MD, MBA, FACP

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Chronic Lymphocytic Leukemia and a Pandemic: A Bad Combination

Brad Kahl, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Combinatorial BCL-2 Inhibition for ALL of the Leukemias: The Sum Is More Than the Parts

Sarah K. Tasian, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

How a Call to Action Will Revolutionize Sickle Cell Disease

Ahmar U. Zaidi, MD,Caterina P. Minniti, MD,Ifeyinwa (Ify) Osunkwo, MD, MPH

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Inflammatory Crosstalk Drives Clonal Hematopoiesis

Adam Mead, MD, PhD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

This Year’s Best in Hematology Diagnosis: A New Disease Is Discovered

Robert P. Hasserjian, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Close Modal

Latest
Most Read

Best in Class? DLBclass, a New Classification Tool for Diffuse Large B-Cell Lymphoma to Facilitate Development of Molecular-Based Precision Treatments

Technology Spotlight
New Dimensions for Platelet Evaluation in Hematology Diagnostics

Viscoelastic Testing for Perioperative Bleeding Management

Committee Corner
The ASH Foundation Is a Reflection of the Society

Truly COSMIC: An ASH Research Collaborative First

Advertisement intended for health care professionals

Table of Contents

Ask the Hematopathologists

Germline Disease in Older Patients: The Case for Vigilance

Features

Reliving #ASH21: The Historic 63rd ASH Annual Meeting

Headlines from Washington

A Look Back at 2021 Shows a Year Full of Creative Advocacy

President's Column

Science Versus the Rising Tide of Distrust

Year’s Best

Oral Maintenance Therapy to Improve Survival in Older Patients With AML

Solid Tumor TIL Therapy Is Infiltrating Multiple Centers With Lympho-“sights” Set on Becoming Standard of Care

Battle of the Clones: Somatic Genetic Rescue of Pediatric Patients With MDS Teaches Us About MDS Biology in 2021 and a Platform for the Future

From Myth to Reality: Achieving a Second Remission in Acute Lymphoblastic Leukemia

The 2021 Year’s Best

Emerging Evidence for Old Drugs (Mycophenolate) and New Ones (Fostamatinib) in the Treatment of Immune Thrombocytopenia

Anticoagulants for Hospitalized Patients With COVID-19: The Year of Randomized Controlled Trials

iStopMM: A Monumental Effort

Chronic Lymphocytic Leukemia and a Pandemic: A Bad Combination

Combinatorial BCL-2 Inhibition for ALL of the Leukemias: The Sum Is More Than the Parts

How a Call to Action Will Revolutionize Sickle Cell Disease

Inflammatory Crosstalk Drives Clonal Hematopoiesis

This Year’s Best in Hematology Diagnosis: A New Disease Is Discovered

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematopathologists

Germline Disease in Older Patients: The Case for Vigilance Free

Features

Reliving #ASH21: The Historic 63rd ASH Annual Meeting Free

Headlines from Washington

A Look Back at 2021 Shows a Year Full of Creative Advocacy Free

President's Column

Science Versus the Rising Tide of Distrust Free

Year’s Best

Oral Maintenance Therapy to Improve Survival in Older Patients With AML Free

Solid Tumor TIL Therapy Is Infiltrating Multiple Centers With Lympho-“sights” Set on Becoming Standard of Care Free

Battle of the Clones: Somatic Genetic Rescue of Pediatric Patients With MDS Teaches Us About MDS Biology in 2021 and a Platform for the Future Free

From Myth to Reality: Achieving a Second Remission in Acute Lymphoblastic Leukemia Free

The 2021 Year’s Best Free

Emerging Evidence for Old Drugs (Mycophenolate) and New Ones (Fostamatinib) in the Treatment of Immune Thrombocytopenia Free

Anticoagulants for Hospitalized Patients With COVID-19: The Year of Randomized Controlled Trials Free

iStopMM: A Monumental Effort Free

Chronic Lymphocytic Leukemia and a Pandemic: A Bad Combination Free

Combinatorial BCL-2 Inhibition for ALL of the Leukemias: The Sum Is More Than the Parts Free

How a Call to Action Will Revolutionize Sickle Cell Disease Free

Inflammatory Crosstalk Drives Clonal Hematopoiesis Free

This Year’s Best in Hematology Diagnosis: A New Disease Is Discovered Free

Email alerts

ASH Publications

American Society of Hematology

Germline Disease in Older Patients: The Case for Vigilance

Reliving #ASH21: The Historic 63rd ASH Annual Meeting

A Look Back at 2021 Shows a Year Full of Creative Advocacy

Science Versus the Rising Tide of Distrust

Oral Maintenance Therapy to Improve Survival in Older Patients With AML

Solid Tumor TIL Therapy Is Infiltrating Multiple Centers With Lympho-“sights” Set on Becoming Standard of Care

Battle of the Clones: Somatic Genetic Rescue of Pediatric Patients With MDS Teaches Us About MDS Biology in 2021 and a Platform for the Future

From Myth to Reality: Achieving a Second Remission in Acute Lymphoblastic Leukemia

The 2021 Year’s Best

Emerging Evidence for Old Drugs (Mycophenolate) and New Ones (Fostamatinib) in the Treatment of Immune Thrombocytopenia

Anticoagulants for Hospitalized Patients With COVID-19: The Year of Randomized Controlled Trials

iStopMM: A Monumental Effort

Chronic Lymphocytic Leukemia and a Pandemic: A Bad Combination

Combinatorial BCL-2 Inhibition for ALL of the Leukemias: The Sum Is More Than the Parts

How a Call to Action Will Revolutionize Sickle Cell Disease

Inflammatory Crosstalk Drives Clonal Hematopoiesis

This Year’s Best in Hematology Diagnosis: A New Disease Is Discovered